As employers and patients struggle with rising prescription drug costs and limited pricing transparency, several solutions have emerged to help lower expenses. One approach is the cost-plus model, ...

Cuban attributes the US’ high drug prices to PBMs—often considered the “middlemen” within the pharma supply chain—arguing ...